p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?

Identification of p73 as a structural homolog of p53 fueled early studies aimed at determining if it was capable of performing p53-like functions. This led to a conundrum as <i>p73</i> was discovered to be hardly mutated in cancers, and yet, TAp73, the full-length form, was found capable...

Full description

Bibliographic Details
Main Authors: Chao Wang, Cui Rong Teo, Kanaga Sabapathy
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/4/1346
_version_ 1811193016411488256
author Chao Wang
Cui Rong Teo
Kanaga Sabapathy
author_facet Chao Wang
Cui Rong Teo
Kanaga Sabapathy
author_sort Chao Wang
collection DOAJ
description Identification of p73 as a structural homolog of p53 fueled early studies aimed at determining if it was capable of performing p53-like functions. This led to a conundrum as <i>p73</i> was discovered to be hardly mutated in cancers, and yet, TAp73, the full-length form, was found capable of performing p53-like functions, including transactivation of many p53 target genes in cancer cell lines. Generation of mice lacking p73/TAp73 revealed a plethora of developmental defects, with very limited spontaneous tumors arising only at a later stage. Concurrently, novel TAp73 target genes involved in cellular growth promotion that are not regulated by p53 were identified, mooting the possibility that TAp73 may have diametrically opposite functions to p53 in tumorigenesis. We have therefore comprehensively evaluated the TAp73 target genes identified and validated in human cancer cell lines, to examine their contextual relevance. Data from focused studies aimed at appraising if p53 targets are also regulated by TAp73&#8212;often by TAp73 overexpression in cell lines with non-functional p53&#8212;were affirmative. However, genome-wide and phenotype-based studies led to the identification of TAp73-regulated genes involved in cellular survival and thus, tumor promotion. Our analyses therefore suggest that TAp73 may not necessarily be p53&#8217;s natural substitute in enforcing tumor suppression. It has likely evolved to perform unique functions in regulating developmental processes and promoting cellular growth through entirely different sets of target genes that are not common to, and cannot be substituted by p53. The p53-related targets initially reported to be regulated by TAp73 may therefore represent an experimental possibility rather than the reality.
first_indexed 2024-04-12T00:01:20Z
format Article
id doaj.art-1495d26ba11348afb336384f1e7098d5
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-12T00:01:20Z
publishDate 2020-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1495d26ba11348afb336384f1e7098d52022-12-22T03:56:14ZengMDPI AGInternational Journal of Molecular Sciences1422-00672020-02-01214134610.3390/ijms21041346ijms21041346p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?Chao Wang0Cui Rong Teo1Kanaga Sabapathy2Division of Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore 169610, SingaporeCancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore 169857, SingaporeDivision of Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, Singapore 169610, SingaporeIdentification of p73 as a structural homolog of p53 fueled early studies aimed at determining if it was capable of performing p53-like functions. This led to a conundrum as <i>p73</i> was discovered to be hardly mutated in cancers, and yet, TAp73, the full-length form, was found capable of performing p53-like functions, including transactivation of many p53 target genes in cancer cell lines. Generation of mice lacking p73/TAp73 revealed a plethora of developmental defects, with very limited spontaneous tumors arising only at a later stage. Concurrently, novel TAp73 target genes involved in cellular growth promotion that are not regulated by p53 were identified, mooting the possibility that TAp73 may have diametrically opposite functions to p53 in tumorigenesis. We have therefore comprehensively evaluated the TAp73 target genes identified and validated in human cancer cell lines, to examine their contextual relevance. Data from focused studies aimed at appraising if p53 targets are also regulated by TAp73&#8212;often by TAp73 overexpression in cell lines with non-functional p53&#8212;were affirmative. However, genome-wide and phenotype-based studies led to the identification of TAp73-regulated genes involved in cellular survival and thus, tumor promotion. Our analyses therefore suggest that TAp73 may not necessarily be p53&#8217;s natural substitute in enforcing tumor suppression. It has likely evolved to perform unique functions in regulating developmental processes and promoting cellular growth through entirely different sets of target genes that are not common to, and cannot be substituted by p53. The p53-related targets initially reported to be regulated by TAp73 may therefore represent an experimental possibility rather than the reality.https://www.mdpi.com/1422-0067/21/4/1346cancer cell linesp53tap73transcriptional targetstumor suppression
spellingShingle Chao Wang
Cui Rong Teo
Kanaga Sabapathy
p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
International Journal of Molecular Sciences
cancer cell lines
p53
tap73
transcriptional targets
tumor suppression
title p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
title_full p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
title_fullStr p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
title_full_unstemmed p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
title_short p53-Related Transcription Targets of TAp73 in Cancer Cells—Bona Fide or Distorted Reality?
title_sort p53 related transcription targets of tap73 in cancer cells bona fide or distorted reality
topic cancer cell lines
p53
tap73
transcriptional targets
tumor suppression
url https://www.mdpi.com/1422-0067/21/4/1346
work_keys_str_mv AT chaowang p53relatedtranscriptiontargetsoftap73incancercellsbonafideordistortedreality
AT cuirongteo p53relatedtranscriptiontargetsoftap73incancercellsbonafideordistortedreality
AT kanagasabapathy p53relatedtranscriptiontargetsoftap73incancercellsbonafideordistortedreality